Sales of analgesics are expected to see a small decline over the forecast period with demand set to stabilise to more normalised levels. As Italians gradually restore their immune systems they are likely to become less likely to contract cold, flu and COVID-19, which in turn should lead to a lower number of flu and COVID-19 cases and thus a decreasing demand for acetaminophen, aspirin and ibuprofen, compared to 2022 and 2023 levels.
Brands are expected to continue focusing on stimulating growth by adding specific pain positionings for their products, such as for menstrual pain, headache, cervical pain, arthritis, back pain. Others are focusing on offering new delivery mechanisms, including being fast acting, extended release, or convenient mono-dose formats to be consumed on the go without water.
Analgesics is a relatively mature category with these products typically purchased reactively to treat pain. However, despite this maturity, sales will likely continue to benefit from the growing culture towards self-medication in the post-pandemic period.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Understand the latest market trends and future growth opportunities for the Analgesics industry in Italy with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Italy, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See All of Our DefinitionsThis report originates from Passport, our Analgesics research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!